共 50 条
- [1] MINIMAL RESIDUAL DISEASE (MRD) BY MULTIPARAMETER FLOW CYTOMETRY (MFC) AND NEXT-GENERATION SEQUENCING (NGS) IN NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA (NDMM): RESULTS FROM THE FORTE TRIALHAEMATOLOGICA, 2021, 106 (10) : 74 - 74Oliva, S.Genuardi, E.Rota-Scalabrini, D.Zamagni, E.Auclair, D.Jacob, A. P.Zambello, R.Spadano, A.Giuliani, N.Cuoghi, A.De Rosa, L.Visca, L.Gozzetti, A.Pietrantuono, G.Patriarca, F.de Fabritiis, P.Aquino, S.Kirsch, I. R.Offidani, M.Belotti, A.Musto, P.Boccadoro, M.Gay, F.
- [2] Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte TrialBLOOD, 2020, 136Oliva, StefaniaGenuardi, ElisaPetrucci, Maria TeresaD'Agostino, MattiaAuclair, DanielSpadano, AntonioJacob, Allison P.Cea, MicheleDe Rosa, LucaGozzetti, AlessandroRuggeri, MarinaCapra, AndreaGilestro, MilenaPescosta, NorbertPalmas, Angelo D.Siniscalchi, AgostinaKirsch, Ilan R.Corradini, PaoloMusto, PellegrinoBoccadoro, MarioZamagni, ElenaGay, Francesca
- [3] Minimal Residual Disease Evaluation By Multiparameter Flow Cytometry and Next Generation Sequencing in the Forte Trial for Newly Diagnosed Multiple Myeloma PatientsBLOOD, 2019, 134Oliva, StefaniaGenuardi, ElisaBelotti, AngeloFrascione, Pio Manlio MirkoGalli, MonicaCapra, AndreaOffidani, MassimoVozella, FedericoZambello, RenatoAuclair, DanielSiniscalchi, AgostinaYesil, JenniferAnnibali, OmbrettaKirsch, Ilan M.Caltagirone, SimonaJacob, Allison P.Ballanti, StelvioPalmas, Angelo D.Ledda, AntonioCorradini, PaoloOmede, PaolaCavo, MicheleMusto, PellegrinoBoccadoro, MarioGay, Francesca
- [4] Landscape of Next Generation Sequencing (NGS)-based Minimal Residual Disease (MRD) assays for Multiple Myeloma (MM) in ChinaEUROPEAN JOURNAL OF CANCER, 2024, 211 : S80 - S80Shen, S.Dan, D.Yao, Z.
- [5] Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts)BLOOD, 2018, 132Dold, Sandra M.Riebl, VeronikaWider, DagmarFollo, MarieMueller, Stefan J.Bartsch, IngridPantic, MilenaMiething, CorneliusKiote-Schmidt, ChrissoulaKortuem, K. MartinZlei, MihaelaAzab, Abdel KareemBinder, MaschaRawluk, JustynaDuyster, JustusZeiser, RobertWaesch, RalphEngelhardt, Monika
- [6] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaBlood Cancer Journal, 10Alejandro MedinaNoemi PuigJuan Flores-MonteroCristina JimenezM.-Eugenia SarasqueteMaría Garcia-AlvarezIsabel Prieto-CondeCarmen ChillonMiguel AlcocebaNorma C. GutierrezAlbert OriolLaura RosinolJoan BladèMercedes GironellaMiguel T. HernandezVeronica Gonzalez-CalleMaria-Teresa CedenaBruno PaivaJesus F. San-MiguelJuan-Jose LahuertaMaria-Victoria MateosJoaquin Martinez-LopezAlberto OrfaoMarcos GonzalezRamon Garcia-Sanz
- [7] Minimal residual disease (MRD) monitoring by multiparameter flow cytometry (MFC) in newly diagnosed transplant eligible multiple myeloma (MM) patients: Results from the EMN02/HO95 phase 3 trial.JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Oliva, StefaniaBruinink, Davine Hofste opRIhova, LucieSpada, Stefanovan der Holt, BronnoTroia, RossellaGambella, ManuelaPantani, LuciaGrammatico, SaraGilestro, MilenaOffidani, MassimoRibolla, RossellaGalli, MonicaHajek, RomanPalumbo, AntonioCava, MicheleOmede, Paolavan der, Vincent
- [8] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaBLOOD CANCER JOURNAL, 2020, 10 (10)Medina, AlejandroPuig, NoemiFlores-Montero, JuanJimenez, CristinaSarasquete, M. -EugeniaGarcia-Alvarez, MariaPrieto-Conde, IsabelChillon, CarmenAlcoceba, MiguelGutierrez, Norma C.Oriol, AlbertRosinol, LauraBlade, JoanGironella, MercedesHernandez, Miguel T.Gonzalez-Calle, VeronicaCedena, Maria-TeresaPaiva, BrunoSan-Miguel, Jesus F.Lahuerta, Juan-JoseMateos, Maria-VictoriaMartinez-Lopez, JoaquinOrfao, AlbertoGonzalez, MarcosGarcia-Sanz, Ramon
- [9] Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple MyelomaBLOOD, 2022, 140 : 7249 - 7250Wang, QingqingYao, LiZhu, MingqingYan, LingzhiJin, SongShang, JingjingShi, XiaolanZhai, YingyingYan, ShuangYao, WeiqinYou HongyingWu, DepeiFu, Chengcheng
- [10] New Alternatives for the Evaluation of Minimal Residual Disease (MRD) Detection By Next Generation Sequencing in Multiple MyelomaBLOOD, 2017, 130Medina, AlejandroJimenez, CristinaPuig, NoemiSanchez-Vega, BeatrizFlores-Montero, JuanGonzalez, MarcosCalasanz, Maria JoseAyala, Rosa M.Sarasquete, Maria E.Paiva, BrunoCedena, Maria TeresaFernandez-Mercado, MartaRapado, InmaculadaRosinol, LauraOcio, Enrique M.Oriol, AlbertAlcoceba, MiguelHernandez, Miguel T.Martinez, Rafael MartinezMateos, Maria-VictoriaLahuerta, Juan-JoseBlade, JoanOrfao, AlbertoSan Miguel, Jesus F.Martinez-Lopez, JoaquinGarcia-Sanz, Ramon